A new study is using artificial intelligence to stop the trial-and-error process of prescribing antidepressants to patients. Two-thirds of patients with depression do not respond to their first prescription. Dr. Jay Faber joined CBSN to explain how artificial intelligence tracks brain activity and how patients may benefit. Source